These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37748414)

  • 1. The burden of chronic drug-refractory focal onset epilepsy: Can it be prevented?
    Ben-Menachem E; Schmitz B; Kälviäinen R; Thomas RH; Klein P
    Epilepsy Behav; 2023 Nov; 148():109435. PubMed ID: 37748414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
    Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
    Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of epilepsy and unmet need in people with focal seizures.
    Ioannou P; Foster DL; Sander JW; Dupont S; Gil-Nagel A; Drogon O'Flaherty E; Alvarez-Baron E; Medjedovic J
    Brain Behav; 2022 Sep; 12(9):e2589. PubMed ID: 36017757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to use new breakthrough treatments for epilepsy.
    Klein P; Krauss GL; Steinhoff BJ; Devinsky O; Sperling MR
    Epilepsia; 2023 Jun; 64(6):1458-1465. PubMed ID: 36855241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Felbamate add-on therapy for drug-resistant focal epilepsy.
    Shi LL; Bresnahan R; Martin-McGill KJ; Dong J; Ni H; Geng J
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD008295. PubMed ID: 31425617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
    Villanueva V; Serratosa JM; Toledo M; Ángel Calleja M; Navarro A; Sabaniego J; Pérez-Domper P; Álvarez-Barón E; Subías S; Gil A
    Epilepsy Behav; 2023 Feb; 139():109054. PubMed ID: 36603345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rufinamide add-on therapy for refractory epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011772. PubMed ID: 29691835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistant epilepsy: Definition, pathophysiology, and management.
    Mesraoua B; Brigo F; Lattanzi S; Abou-Khalil B; Al Hail H; Asadi-Pooya AA
    J Neurol Sci; 2023 Sep; 452():120766. PubMed ID: 37597343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felbamate add-on therapy for drug-resistant focal epilepsy.
    Shi LL; Bresnahan R; Martin-McGill KJ; Dong J; Ni H; Geng J
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008295. PubMed ID: 35914010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the burden of generalized tonic-clonic seizures in patients with drug-resistant epilepsy.
    Sheikh SR; Thompson N; Frech F; Malhotra M; Jehi L
    Epilepsia; 2020 Aug; 61(8):1627-1637. PubMed ID: 32658343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of anti-seizure medication (ASM) use in pediatric patients with surgically managed epilepsy: A retrospective review of data from Boston Children's Hospital.
    Wang S; Rotenberg A; Bolton J
    Epilepsy Res; 2020 Feb; 160():106257. PubMed ID: 32004867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly purified cannabidiol in the treatment of drug-resistant epilepsies: A real-life impact on seizure frequency, quality of life, behavior, and sleep patterns from a single Italian center.
    Ferrera G; Ricci E; Vignoli A; Savini MN; Viganò I; Chiesa V; Caputo D; Zambrelli E; La Briola F; Turner K; Canevini MP
    Epilepsy Behav; 2023 Oct; 147():109409. PubMed ID: 37677907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol add-on therapy for drug-resistant focal epilepsy.
    Brigo F; Igwe SC; Bragazzi NL
    Cochrane Database Syst Rev; 2020 May; 5(5):CD009887. PubMed ID: 32468572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011501. PubMed ID: 30920649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacosamide add-on therapy for focal epilepsy.
    Babar RK; Bresnahan R; Gillespie CS; Michael BD
    Cochrane Database Syst Rev; 2021 May; 5(5):CD008841. PubMed ID: 33998660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.